期刊文献+

半夏白术天麻汤联合温胆汤治疗原发性高血压有效性及安全性的Meta分析 被引量:5

Efficacy and Safety of Banxia Baizhu Tianma Decoction Combined with Wendan Decoction in the Treatment of Essential Hypertension:a Meta-analysis
下载PDF
导出
摘要 目的系统评价半夏白术天麻汤联合温胆汤治疗原发性高血压的有效性和安全性。方法计算机检索中国知网、万方、维普数据库、EMbase、PubMed、SinoMed、the Cochrane Library中关于半夏白术天麻汤联合温胆汤治疗原发性高血压的临床随机对照试验,由2位研究者独立纳入文献、提取数据和质量评价,采用RevMan 5.4软件进行Meta分析。结果共纳入26篇文献,涉及2790例病人。Meta分析结果表明:与对照组比较,试验组治疗总有效率[OR=4.98,95%CI(3.65,6.78),P<0.00001]升高,收缩压[MD=-12.51,95%CI(-14.41,-10.61),P<0.00001]、舒张压[MD=-9.75,95%CI(-11.36,-8.14),P<0.00001]和不良反应发生率[OR=0.24,95%CI(0.17,0.36),P<0.00001]降低。漏斗图不对称,可能存在发表偏倚。结论现有证据表明:半夏白术天麻汤联合温胆汤治疗原发性高血压具有较好的疗效和较高的安全性。 Objective To systematically evaluate the efficacy and safety of Banxia Baizhu Tianma Decoction combined with Wendan Decoction in the treatment of essential hypertension.Methods The randomized controlled trials of Banxia Baizhu Tianma Decoction combined with Wendan Decoction in the treatment of essential hypertension were retrieved from CNKI,VIP,WanFang,EMbase,PubMed,SinoMed,and the Cochrane Library by computer.Two researchers independently included literature,extracted data,and evaluated the quality.RevMan 5.4 software was used for Meta-analysis.Results A total of 26 literatures were included,including 2790 patients.The results of Meta-analysis showed that compared with the control group,the total efficacy in the observation group[OR=4.98,95%CI(3.65,6.78),P<0.00001]was increased,and the systolic blood pressure[MD=-12.51,95%CI(-14.41,-10.61),P<0.00001],diastolic blood pressure[MD=-9.75,95%CI(-11.36,-8.14),P<0.00001]and the incidence of adverse reactions[OR=0.24,95%CI(0.17,0.36),P<0.00001]were lower.The funnel plot was asymmetric and bias existed.Conclusion The current evidence showed that Banxia Baizhu Tianma Decoction combined with Wendan Decoction in the treatment of essential hypertension was effective and high safety.
作者 周宗慧 王泓午 朱青青 王东军 孙璇 ZHOU Zonghui;WANG Hongwu;ZHU Qingqing;WANG Dongjun;SUN Xuan(Tianjin University of Traditional Chinese Medicine,Tianjin 301617,China)
机构地区 天津中医药大学
出处 《中西医结合心脑血管病杂志》 2022年第20期3659-3665,共7页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
基金 国家重点研发计划课题(No.2017YFC1703305) 天津中医药大学研究生科创-中医面舌诊(No.JJ1901010341)。
关键词 原发性高血压 半夏白术天麻汤 温胆汤 疗效 安全性 META分析 essential hypertension Banxia Baizhu Tianma Decoction Wendan Decoction efficacy safety Meta-analysis
  • 相关文献

参考文献23

二级参考文献90

共引文献100

同被引文献68

引证文献5

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部